Cash Cash Equivalents - Bergenbio ASA (OSE:BGBIO) - Alpha Spread
B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 9.07 NOK 1.06% Market Closed
Market Cap: 368.3m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Bergenbio ASA
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bergenbio ASA
Cash & Cash Equivalents Peer Comparison

Comparables:
HBC
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
Bergenbio ASA
OSE:BGBIO
Cash & Cash Equivalents
kr117.3m
CAGR 3-Years
-44%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Cash & Cash Equivalents
kr22.2m
CAGR 3-Years
-46%
CAGR 5-Years
-10%
CAGR 10-Years
36%
L
Lytix Biopharma AS
OSE:LYTIX
Cash & Cash Equivalents
kr27.4m
CAGR 3-Years
-1%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Cash & Cash Equivalents
kr173m
CAGR 3-Years
2%
CAGR 5-Years
44%
CAGR 10-Years
23%
N
Nykode Therapeutics ASA
OSE:NYKD
Cash & Cash Equivalents
$147.3m
CAGR 3-Years
-6%
CAGR 5-Years
30%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Cash & Cash Equivalents
kr41.8m
CAGR 3-Years
-48%
CAGR 5-Years
-38%
CAGR 10-Years
N/A

See Also

What is Bergenbio ASA's Cash & Cash Equivalents?
Cash & Cash Equivalents
117.3m NOK

Based on the financial report for Mar 31, 2024, Bergenbio ASA's Cash & Cash Equivalents amounts to 117.3m NOK.

What is Bergenbio ASA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-17%

Over the last year, the Cash & Cash Equivalents growth was 61%. The average annual Cash & Cash Equivalents growth rates for Bergenbio ASA have been -44% over the past three years , -17% over the past five years .

Back to Top